News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|October 12, 2021

Pros and Cons of Available Influenza Vaccines

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

Episodes in this series

Experts on Influenza

EP. 1 Evolving Influenza Trends Throughout COVID-19 Pandemic

Experts on Influenza

EP. 2 The Impact of Distancing, Masks, and Vaccination on Influenza

Experts on Influenza

EP. 3 Feasibility of Concurrent COVID-19 and Influenza Vaccination

Experts on Influenza

EP. 4 Similarities and Differences in COVID-19 and Influenza

Experts on Influenza

EP. 5 Identifying Patients at High Risk for Influenza Complications

Experts on Influenza

EP. 6 Pros and Cons of Available Influenza Vaccines

Experts on Influenza

EP. 7 Influenza Vaccination Timing and Reluctance

Experts on Influenza

EP. 8 Vaccination Misconceptions and Educating Patients

Experts on Influenza

EP. 9 Influenza Case 1: Female Patient With Asthma and Egg Allergy

Experts on Influenza

EP. 10 Influenza Case 2: Male Patient With Chronic Health Conditions

Charles Vega, MD, discusses the indications, administration requirements, dosing schedules, adverse events, and any contraindications that exist between each available influenza vaccines that is currently available.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Latest CME

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

The problem with AstraZeneca’s Farxiga TV ad; Americans are unsure about Mifepristone; new alternative HPV test endorsed by ACS – Morning Medical Update

From health care AI pilots to proof: Closing the clinical loop with trusted, connected, and auditable AI in 2026

Regulations, reimbursement, prior auths, advocacy: ACP and the state of U.S. health care

SS Innovations files 510(k) submission for SSi Mantra surgical robot

Collaborative care: Don’t forget about youth behavioral health

© 2025 MJH Life Sciences^®

All rights reserved.